Yes, MBP can serve as a biomarker for certain neurological conditions. Elevated levels of MBP in cerebrospinal fluid (CSF) can indicate myelin damage, which is often observed in diseases like multiple sclerosis. Monitoring MBP levels can help in the diagnosis and progression monitoring of such diseases.